Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2 ): a review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A2 (Lp-PLA2 ): a review ; volume:10 ; number:1 ; day:28 ; month:9 ; year:2011 ; pages:1-10 ; date:12.2011
Lipids in health and disease ; 10, Heft 1 (28.9.2011), 1-10, 12.2011
- Urheber
-
Silva, Isis T.
Mello, Ana PQ
Damasceno, Nágila RT
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1476-511X-10-170
- URN
-
urn:nbn:de:101:1-2021082420211949440940
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Silva, Isis T.
- Mello, Ana PQ
- Damasceno, Nágila RT
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum
Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitor [18F]GSK2647544 in Healthy Male Subjects
Lipopolysaccharide (LPS)-induced inflammation in RAW264.7 cells is inhibited by microRNA-494-3p via targeting lipoprotein-associated phospholipase A2
Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study
Lipoprotein assoziierte Phospholipase A2 als Prädiktor für subklinische Atherosklerose bei chronisch nierenkranken dialysepflichtigen Patienten
Elevated lipoprotein(a) and lipoprotein-associated phospholipase A2 are associated with unfavorable functional outcomes in patients with ischemic stroke
Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes
Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk
Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum
Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitor [18F]GSK2647544 in Healthy Male Subjects
Lipopolysaccharide (LPS)-induced inflammation in RAW264.7 cells is inhibited by microRNA-494-3p via targeting lipoprotein-associated phospholipase A2
Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study
Lipoprotein assoziierte Phospholipase A2 als Prädiktor für subklinische Atherosklerose bei chronisch nierenkranken dialysepflichtigen Patienten
Elevated lipoprotein(a) and lipoprotein-associated phospholipase A2 are associated with unfavorable functional outcomes in patients with ischemic stroke
Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes
Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk
Correlation of lipoprotein-associated phospholipase A2 and cerebral microbleeds in patients with acute ischaemic stroke
Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum
Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Inhibitor [18F]GSK2647544 in Healthy Male Subjects
Lipopolysaccharide (LPS)-induced inflammation in RAW264.7 cells is inhibited by microRNA-494-3p via targeting lipoprotein-associated phospholipase A2
Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in adolescents: the healthy young cross-sectional study
Lipoprotein assoziierte Phospholipase A2 als Prädiktor für subklinische Atherosklerose bei chronisch nierenkranken dialysepflichtigen Patienten
Elevated lipoprotein(a) and lipoprotein-associated phospholipase A2 are associated with unfavorable functional outcomes in patients with ischemic stroke
Effect of intensive insulin treatment on plasma levels of lipoprotein-associated phospholipase A2 and secretory phospholipase A2 in patients with newly diagnosed type 2 diabetes
Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk